These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Lipid oxidation inactivates the anticoagulant function of protein Z-dependent protease inhibitor (ZPI). Huang X, Liu B, Wei Y, Beyea R, Yan H, Olson ST. J Biol Chem; 2017 Sep 01; 292(35):14625-14635. PubMed ID: 28717005 [Abstract] [Full Text] [Related]
6. Protein Z-dependent protease inhibitor (ZPI) is a physiologically significant inhibitor of prothrombinase function. Huang X, Swanson R, Kroh HK, Bock PE. J Biol Chem; 2019 May 10; 294(19):7644-7657. PubMed ID: 30918026 [Abstract] [Full Text] [Related]
8. Characterization of the protein Z-dependent protease inhibitor. Han X, Fiehler R, Broze GJ. Blood; 2000 Nov 01; 96(9):3049-55. PubMed ID: 11049983 [Abstract] [Full Text] [Related]
9. Protein Z-dependent protease inhibitor binds to the C-terminal domain of protein Z. Rezaie AR, Bae JS, Manithody C, Qureshi SH, Yang L. J Biol Chem; 2008 Jul 18; 283(29):19922-6. PubMed ID: 18502758 [Abstract] [Full Text] [Related]
10. Heparin activation of protein Z-dependent protease inhibitor (ZPI) allosterically blocks protein Z activation through an extended heparin-binding site. Huang X, Swanson R, Olson ST. J Biol Chem; 2022 Jun 18; 298(6):102022. PubMed ID: 35551912 [Abstract] [Full Text] [Related]
11. Crystal structure of protein Z-dependent inhibitor complex shows how protein Z functions as a cofactor in the membrane inhibition of factor X. Wei Z, Yan Y, Carrell RW, Zhou A. Blood; 2009 Oct 22; 114(17):3662-7. PubMed ID: 19528533 [Abstract] [Full Text] [Related]
12. Structural basis for catalytic activation of protein Z-dependent protease inhibitor (ZPI) by protein Z. Huang X, Yan Y, Tu Y, Gatti J, Broze GJ, Zhou A, Olson ST. Blood; 2012 Aug 23; 120(8):1726-33. PubMed ID: 22786881 [Abstract] [Full Text] [Related]
13. Identification of factor Xa residues critical for interaction with protein Z-dependent protease inhibitor: both active site and exosite interactions are required for inhibition. Rezaie AR, Manithody C, Yang L. J Biol Chem; 2005 Sep 23; 280(38):32722-8. PubMed ID: 16079143 [Abstract] [Full Text] [Related]
14. Protein Z circulates in plasma in a complex with protein Z-dependent protease inhibitor. Tabatabai A, Fiehler R, Broze GJ. Thromb Haemost; 2001 Apr 23; 85(4):655-60. PubMed ID: 11341501 [Abstract] [Full Text] [Related]
15. A computational modeling and molecular dynamics study of the Michaelis complex of human protein Z-dependent protease inhibitor (ZPI) and factor Xa (FXa). Chandrasekaran V, Lee CJ, Lin P, Duke RE, Pedersen LG. J Mol Model; 2009 Aug 23; 15(8):897-911. PubMed ID: 19172319 [Abstract] [Full Text] [Related]
16. Suppressing protein Z-dependent inhibition of factor Xa improves coagulation in hemophilia A. Girard TJ, Lasky NM, Grunz K, Broze GJ. J Thromb Haemost; 2019 Jan 23; 17(1):149-156. PubMed ID: 30451376 [Abstract] [Full Text] [Related]
18. Co-localization of Protein Z, Protein Z-Dependent protease inhibitor and coagulation factor X in human colon cancer tissue: implications for coagulation regulation on tumor cells. Sierko E, Wojtukiewicz MZ, Zimnoch L, Tokajuk P, Ostrowska-Cichocka K, Kisiel W. Thromb Res; 2012 Apr 23; 129(4):e112-8. PubMed ID: 22424030 [Abstract] [Full Text] [Related]
19. Mechanism of protein-z-mediated inhibition of coagulation factor xa by z-protein-dependent inhibitor: a molecular dynamic approach. Dayer MR, Ghayour O, Dayer MS. ISRN Hematol; 2012 Apr 23; 2012():762728. PubMed ID: 22536522 [Abstract] [Full Text] [Related]
20. Engineering a protein Z-dependent protease inhibitor (ZPI) mutant as a novel antagonist of ZPI anticoagulant function for hemophilia treatment. Huang X. J Thromb Haemost; 2019 Oct 23; 17(10):1655-1660. PubMed ID: 31423718 [Abstract] [Full Text] [Related] Page: [Next] [New Search]